Bioactive calcium phosphate silicate ceramic surface-modified PLGA for tendon-to-bone healing

Tendon-to-bone healing remains a major clinical challenge due to the distinct biological and mechanical properties of these tissues. Prior research has shown that successful integration at the tendon-bone interface requires materials that mimic the natural gradient of composition and function. However, no prior work had resolved how to effectively translate this concept into a practical composite material. Existing studies have focused on either bone or tendon-specific scaffolds but not on the transitional zone. This gap motivated the exploration of new composite films that could bridge the tendon-bone interface. The need for a material that supports both cell attachment and osteogenic activity remains unmet. Current materials lack the layered chemical structure needed to match the tendon-bone interface. This study addresses that limitation by introducing a novel composite approach. The aim is to provide a solution that aligns with the biological complexity of tendon-bone healing.

The goal of this study was to develop a composite material that mimics the tendon-bone interface's layered chemical structure. The researchers aimed to address the challenge of tendon-to-bone healing by designing a material that supports both cell adhesion and osteogenic activity. They proposed using a bioactive calcium phosphate silicate ceramic (CPS) to modify the surface of poly(lactic-co-glycolic acid) (PLGA) films. This approach was intended to enhance the material's biological performance. The specific problem addressed is the lack of a composite material with tunable properties for tendon-bone integration. The motivation stems from the need for a material that can bridge the distinct characteristics of tendon and bone. The researchers sought to evaluate the physicochemical and biological behaviors of the CPS-PLGA composite. The study's success depends on demonstrating improved cell compatibility and osteogenic potential.

The researchers prepared CPS-modified PLGA films using electron beam evaporation (EBE) to coat the surface of PLGA films. The composite films were analyzed for their physicochemical properties, including hydrophilicity and zeta potential. Cell culture experiments were conducted using rat bone marrow mesenchymal stem cells (rBMSCs) and NIH3T3 fibroblasts. The study measured cell attachment and proliferation rates on the modified surfaces. Osteogenic activity was assessed through specific markers of bone formation. The EBE technique allowed precise control over the CPS layer's thickness and composition. The films were characterized using standard analytical methods for surface properties. The results were compared to unmodified PLGA films to evaluate the impact of CPS modification.

The CPS-modified PLGA films showed significantly improved hydrophilicity compared to unmodified films. The zeta potential measurements indicated a more negative surface charge, which may enhance cell adhesion. Cell culture experiments revealed increased attachment and proliferation of rBMSCs and NIH3T3 cells on the modified surfaces. The CPS layer also supported higher osteogenic activity, as indicated by relevant markers. These findings suggest that the CPS modification enhances the biological performance of PLGA. The hydrophilicity and zeta potential changes were statistically significant. The cell proliferation rates were higher on CPS-modified surfaces. The osteogenic activity was notably improved compared to controls.

The authors concluded that the CPS-modified PLGA films have promising potential for tendon-bone healing applications. The improved hydrophilicity and zeta potential suggest better cell-material interactions. The enhanced cell attachment and proliferation indicate favorable conditions for tissue regeneration. The increased osteogenic activity supports the material's role in bone formation. These findings align with the study's aim of developing a composite material that mimics the tendon-bone interface. The results suggest that the CPS modification is a viable strategy for improving PLGA's biological performance. The study's outcomes are consistent with the hypothesis that surface modification can enhance healing outcomes. The authors propose that this material could be used in clinical settings for tendon-bone repair.